Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Postherpetic neuralgia with pain present for at least 9 months
You may not be if
Active herpes zoster skin rash
Anticipated treatment for postherpetic neuralgia during the first 3 months of the study, including oral and topical medications, acupuncture, spinal cord stimulation, transcutaneous nerve stimulation (TNS), or trigger point injection
Anticipated treatment with pain medication for the treatment of postherpetic neuralgia during the first 3 months of the study
Use of capsaicin treatment for postherpetic neuralgia within 6 months, or anticipated use during the first 3 months of the study
Use of botulinum toxin of any serotype for any reason within 6 months, or anticipated use during the study
